Technical Analysis for CRMD - CorMedix Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical CRMD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Cup with Handle | Other | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Cup with Handle | Other | -1.67% | |
| Overbought Stochastic | Strength | -1.67% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Cup with Handle | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 10 DMA Support | about 7 hours ago | |
| Fell Below Previous Day's Low | about 7 hours ago | |
| 60 Minute Opening Range Breakdown | about 8 hours ago | |
| Down 3% | about 8 hours ago | |
| 1.5x Volume Pace | about 8 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2020
CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine CRM Catheter Dysfunction Therapeutic Product Dialysis Therapeutic Products Catheters Stage Pharmaceutical Membrane Technology Hemodialysis Pharmaceutical And Medical Kidney Nephrology Renal Dialysis Pharmaceutical And Medical Device Rockwell Medical Anticoagulant
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine CRM Catheter Dysfunction Therapeutic Product Dialysis Therapeutic Products Catheters Stage Pharmaceutical Membrane Technology Hemodialysis Pharmaceutical And Medical Kidney Nephrology Renal Dialysis Pharmaceutical And Medical Device Rockwell Medical Anticoagulant
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.42 |
| 52 Week Low | 2.16 |
| Average Volume | 407,625 |
| 200-Day Moving Average | 5.70 |
| 50-Day Moving Average | 7.78 |
| 20-Day Moving Average | 8.20 |
| 10-Day Moving Average | 8.61 |
| Average True Range | 0.49 |
| ADX | 23.84 |
| +DI | 19.78 |
| -DI | 14.52 |
| Chandelier Exit (Long, 3 ATRs ) | 7.63 |
| Chandelier Exit (Short, 3 ATRs ) | 8.27 |
| Upper Bollinger Band | 9.33 |
| Lower Bollinger Band | 7.07 |
| Percent B (%b) | 0.78 |
| BandWidth | 27.60 |
| MACD Line | 0.31 |
| MACD Signal Line | 0.24 |
| MACD Histogram | 0.0732 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.46 | ||||
| Resistance 3 (R3) | 9.44 | 9.22 | 9.35 | ||
| Resistance 2 (R2) | 9.22 | 9.06 | 9.23 | 9.32 | |
| Resistance 1 (R1) | 9.03 | 8.97 | 8.92 | 9.05 | 9.28 |
| Pivot Point | 8.81 | 8.81 | 8.76 | 8.82 | 8.81 |
| Support 1 (S1) | 8.62 | 8.65 | 8.51 | 8.64 | 8.40 |
| Support 2 (S2) | 8.40 | 8.56 | 8.41 | 8.36 | |
| Support 3 (S3) | 8.21 | 8.40 | 8.33 | ||
| Support 4 (S4) | 8.23 |
